| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Over the past 90 days, insiders at Teva Pharmaceutical Industries Limited (TEVA) have been net sellers, shedding 441,824 shares worth roughly $17.0M on balance.
TEVA sits in the Pharmaceuticals industry within the Health Care sector, so this activity is best read against the sector's broader insider trend.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.12M | - | - | |
| CEO | 1.18M | - | - | |
| Dir | 448.0K | - | - | |
| Dir | 130.1K | - | - | |
| Dir | 127.7K | - | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2021 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 9,795 | $10.85 | $106,284.57 | -16.6% | |
| Mar 1, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 10,912 | $10.83 | $118,185.69 | -8.7% | |
| Feb 16, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 2,098 | $11.12 | $23,335.84 | -2.0% | |
| Feb 16, 2021 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 2,079 | $11.13 | $23,135.32 | -5.0% | |
| Feb 16, 2021 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 3,926 | $11.12 | $43,668.51 | -56.9% | |
| Feb 9, 2021 | Drape Eric51 | Executive VP Global Operations | Sale+OE | 17,979 | $12.72 | $228,709.06 | -32.3% | |
| Feb 9, 2021 | Dethlefs Sven | EVP Global Marketing&Portfolio | Sale+OE | 29,657 | $12.69 | $376,480.79 | -33.3% | |
| Feb 9, 2021 | Daniell Richard | Exec. VP, European Commercial | Sale+OE | 68,422 | $12.72 | $870,389.42 | -86.4% | |
| Feb 9, 2021 | Stark David Matthew53 | Exec. VP Chief Legal Officer | Sale+OE | 65,312 | $12.69 | $829,103.18 | -95.6% | |
| Feb 9, 2021 | Fridriksdottir Hafrun47 | Executive VP, Global R&D | Sale+OE | 29,496 | $12.69 | $374,436.97 | -22.8% |